Relation of genetic polymorphisms of apolipoprotein E, angiotensin converting enzyme, apolipoprotein B-100, and glycoprotein IIIa and early- onset coronary heart disease

Clinical Biochemistry

Volumn 32, Issue 4, 1999, Pages 275-282

  Nassar, Bassam A ^a   Dunn, Jeremy ^a   Title, Lawrence M ^a   O'Neill, Blair J ^a   Kirkland, Susan A ^a   Zayed, Ekram ^a   Bata, Iqbal R ^a   Cantrill, Richard C ^a   Johnstone, Jenny ^a   Dempsey, Gale I ^a   Tan, Meng Hee ^a   Breckenridge, W Carl ^b   Johnstone, David E ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b Efamol Limited   (Canada)

Author keywords

Angiotensin converting enzyme; Apolipoprotein B 100; Apolipoprotein E; Association; Coronary heart disease; Genetic polymorphism; Glycoprotein IIIa

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN E; DIPEPTIDYL CARBOXYPEPTIDASE; GLYCOPROTEIN IIIA;

ADULT; AGED; ALLELISM; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; HEART INFARCTION; HEART TRANSPLANTATION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGE OF ONSET; AGED; ANALYSIS OF VARIANCE; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; APOLIPOPROTEINS E; CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONGEVITY; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; RISK FACTORS; SURVIVAL RATE;

EID: 0032842685     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(99)00017-X     Document Type: Article

References (71)

1. Kannel W.B., Castelli W.P., Gordon T. Serum cholesterol, lipoproteins and the risk of coronary heart disease The Framingham Study . Ann Intern Med. 74:1971;1-12.
2. Rissanen A. Familial occurance of coronary heart disesae effect of age at diagnosis . Am J Cardiol. 44:1979;60-66.
3. Wilson P.W., Myers R.H., Larson M.G., Ordovas J.M., Wolf P.A., Shaefer E.J. Apolipoprotein E alleles, dylipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA. 272:1994;1666-1671.
4. Cambien F. The angiotensin-converting enzyme (ACE) genetic polymorphism its relationship with plasma ACE level and myocardial infarction . Clin Genet. 46:1994;94-101.
5. Hegele R.A., Huang L.S., Herbert P.N., et al. Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. N Engl J Med. 315:1986;1509-1515.
6. Weiss E.J., Bray P.F., Tayback M., et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 334:1996;1090-1094.
7. Utermann G. Apolipoprotein E polymorphism in health and disease. Am Heart J. 113:1987;433-440.
8. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
9. Kuusi T., Nieminen M., Ehnholm C., et al. Apoprotein E polymorphism and coronary artery disease increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients . Arteriosclerosis. 9:1989;237-241.
10. Ehnholm C., Lukka M., Kuusi T., Nikkila E., Uterman G. Apolipoprotein E polymorphism in the Finnish population gene frequencies and relation to lipoprotein concentration . J Lipid Res. 27:1986;227-235.
11. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
12. van Bockxmeer F.M., Mamotte C.D.S. Apolipoprotein e4 homozygosity in young men with coronary heart disease. Lancet. 340:1992;879-880.
13. Payne M.N., Green E., Walker M.R., Beattie J.M., Murray R.G., Jones A.F. Apolipoprotein e4 and coronary artery disease. Lancet. 340:1992;1350.
14. De Knijff P., Jansen H., Lie K.I., Havekes L.M. Apolipoprotein ε4 and coronary artery disease. Lancet. 340:1992;1351.
15. Ou T., Yamakawa-kobayashi K., Arimani T., et al. Methylenetetrahydro- folate reductase and apolipoprotein E polymorphisms are independent risk factors for coronary heart disease in Japenese a case-control study . Atherosclerosis. 137:1998;23-28.
16. Wilson P.W.F. Relation of high-density lipoprotein subfractions and apolipoprotein E isoforms to coronary disease. Clin Chem. 41:1995;165-169.
17. Cambien F., Costerousse O., Tiret L., et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 90:1994;669-676.
18. Tiret L., Rigat B., Visvikis S., et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 51:1992;197-205.
19. Cambien F., Poirier O., Lecerf L., et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
20. Ludwig E., Corneli P.S., Anderson J.L., Marshall H.W., Lalouel J.M., Ward R.H. Angiotensin converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 91:1995;2120-2124.
21. Gardemann A., Weib T., Schwartz O., et al. Heberbosch. gene polymorphism but not catalytic activity of the angiotensin-I converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients. Circulation. 92:1995;2796-2799.
22. Sertic J., Hebrang D., Janus D., et al. Association between deletion polymorphism of the angiotensin- converting enzyme gene and cerebral atherosclerosis. Eur J Clin Chem Clin Biochem. 34:1996;301-304.
23. Ohishi M., Fujii K., Minamino T., et al. A potent genetic risk factor for restenosis. Nature Genet. 5:1993;324-325.
24. Tiret L., Kee F., Poirier O., et al. Deletion polymorphism in angiotensin-converting enzyme gene with parental history of myocardial infarction. Lancet. 341:1993;991-992.
25. Schunkert H., Hense H.W., Holmer S.R., et al. Association between a deletion polymorphism of the angiotensin- converting enzyme gene and left ventricular hypertrophy. N Engl J Med. 330:1994;1634-1638.
26. Marian A.J., Yu Q.T., Workman R., Greve G., Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet. 342:1993;1085-1086.
27. Lechin M., Quinones M.A., Omran A., et al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation. 92:1995;1808-1812.
28. Raynolds M.V., Bristow M.R., Bush E.W., et al. Angiotensin-converting enzyme DD genotype in patients with ischemic or idiopathic dilated cardiomyopathy. Lancet. 342:1993;1073-1075.
29. Berge K.E., Bohn M., Berg K. DNA polymorphism at the locus for angiotensin I- converting enzyme in Norwegian patients with myocardial infarction and controls. Clin Genet. 46:1994;102-104.
30. Miettenen H.E., Korpela K., Hamalainen L., Kontula K. Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet. 94:1994;189-192.
31. Lindpaintner K., Pfeffer M.A., Kreutz R., et al. A prospective evaluation of an angiotensin-converting enzyme polymorphism and the risk of ischemic heart disease. N Engl J Med. 332:1995;706-711.
32. Samani N.J., Martin D.S., Brack M., et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angiography. Lancet. 345:1995;1013-1016.
33. Lindpaintner K., Lee M., Larsom M.G., et al. Absence of association or genetic linkage between the angiotensin-converting enzyme gene and left ventricular mass. N Engl J Med. 334:1996;1023-1028.
34. Rajput-Williams J., Knott T.J., Wallis S.C., et al. Variation of apolipoprotein-B gene is associated with obesity, high blood cholesterol levels, and increased risk of coronary heart disease. Lancet. 2:1988;1442-1446.
35. Genest J.J. Jr, Ordovos J.M., McNamara J.R., et al. DNA polymorphism of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis. 82:1990;7-17.
36. Pan J.P., Chiang A.N., Tai J.J., Wang S.P. Chang MS. Restriction fragment length polymorphism of apolipoprotein B gene in Chinese population coronary heart disease. Clin Chem. 41:1995;424-429.
37. Phillips D.R., Charo I.F., Parise L.V., Fitzgerald L.A. The platelet membrane glycoprotein IIb-IIIa complex. Blood. 1988;831-843.
38. Handin R.I. Platelets and coronary artery disease. N Engl J Med. 334:1996;1126-1128.
39. Newman P.J., Derbes R.S., Aster R.H. The human platelet alloantigens, PIA1 and PIA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest. 83:1989;1778-1781.
40. Mariam A.J., Brugada R., Kleiman N.S. Platelet glycoprotein IIIa PIA polymorphism and myocardial infarction. N Engl J Med. 335:1996;1071-1072.
41. Carter A.M., Ossei-Gerning N., Grant P.J. Platelet glycoprotein IIIa PIA polymorphism and myocardial infarction. N Engl J Med. 335:1996;1072-1073.
42. Ridker P.M., Hennekens C.H., Schmitz C., Stampfer M.J., Lindpaintner K. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke and venous thrombosis. Lancet. 349:1997;385-388.
43. Theolis R., Breckenridge W.C. Characterization of monoclonal antibodies to apolipoprotein(a) and development of a chemiluminescent assay for phenotyping apolipoprotein(a) isoforms. J Immunol Methods. 172:1994;43-58.
44. Hegele R.A., Breckenridge W.C., Brunt J.H., Connelly P.W. Genetic variation in factor VII associated with variation in plasma lipoprotein(a) concentration. Arterioscler Thromb Vasc Biol. 17:1997;1701-1706.
45. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out method for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
46. Hixson J.E., Vernier D.T. Restriction isotyping of human apo E; amplification and cleavage with HhaI. J Lipid Res. 31:1990;545-548.
47. Morash B., Guernsey D.L., Tan M.H., Dempsey G., Nassar B.A. Detection of familial defective apolipoprotein B-100 among patients clinically diagnosed with heterozygous familial hypercholesterolemia in Maritime Canada. Clin Biochem. 27:1994;265-272.
48. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin I converting enzyme gene (DCP1). Nucleic Acid Res. 20:1992;1433.
49. Armitage P., Berry M.A. Statistical methods in medical research, 2nd ed. 1987;Blackwell Scientific Publications, London.
50. Hopkins P.N., Williams R.R. A survey of 246 suggested coronary risk factors. Atherosclerosis. 40:1981;1-52.
51. National Institute of Health Consensus Development Conference Statement: Lowering blood cholesterol to prevent heart disease. JAMA 1985; 253: 2080-6.
52. Anderson K.M., Wilson P.W.F., Odell P.M., Kannel W.B. Framingham Heart Study coronary heart disease risk reduction chart-and updated coronary risk profile. Gold P., Grover S., Roncari D.A.K. Cholesterol and CHD. 1992;3-17 The Parthenon Publishing Group, Perkridge, NJ.
53. Dahlen G.H. Lp(a) lipoprotein in cardiovascular disease (review). Atherosclerosis. 108:1994;111-126.
54. Rhoads G.G., Dahlen G., Berg K., Morten N.E., Dannenberg A.L. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA. 256:1986;2540-2544.
55. Sandcamp M., Funke H., Schulte H., et al. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem. 36:1990;20-23.
56. Schachter F., Faure-Delanef L., Guenot F., et al. Genetic associations with human longevity at the APOE and ACE loci. Nature Genet. 6:1994;29-32.
57. Kervinen K., Savolainen M.J., Salokannel J., et al. Apolipoprotein E and B polymorphism-longevity factors assessed in nonagenarians. Atherosclerosis. 105:1994;89-95.
58. Galinsky D., Tysoe C., Brayne C.E., et al. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis. 129:1997;177-183.
59. Cullen P., Ciganarella A., Brennhausen B., Mohr S., Assmann G., von Eckardstein A. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol hemostasis in human monocyte-derived macrophages. J Clin Invest. 101:1998;1670-1677.
60. Mabuchi H., Itoh H., Takeda M., et al. A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency. Metabolism. 38:1989;115-119.
61. Linton M.F., Atkinson J.B., Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 267:1995;1034-1037.
62. Strickland D.K., Ashcom J.D., Williams S., Burgess W.H., Migliorini M., Argraves W.S. Sequence identity between the a2-macroglobulin receptor and the low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J Biol Chem. 265:1990;17401-17404.
63. Cumming A.M., Robertson F. Polymorphism at the apo E locus in relation to risk of coronary artery disease. Clin Genet. 25:1984;310-313.
64. Lenzen H.J., Assmann G., Buchwalsky R., Schulte H. Assocoation of apolipoprotein E polymorphism, low density lipoprotein cholesterol, and coronary artery disease. Clin Chem. 32:1986;778-781.
65. Eto M., Watanabe K., Makino I. Increased frequencies of apolipoprotein epsilon 2 and epsilon 4 alleles in patients with ischemic heart disease. Clin Genet. 36:1989;183-188.
66. Mattu R.K., Needham E.W.A., Galton D.J., Frangos E., Clark A.J.L., Cahlfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly heart study. Circulation. 91:1995;270-274.
67. Young S.G. Recent progress in understanding apolipoprotein B. Circulation. 82:1990;1574-1594.
68. Hansen P.S., Rudiger N., Tybjaerg-Hansen A., Faegerman O., Gregersen N. Detection of APOB-3500 mutation (glutamine for arginine) by gene amplification and cleavage with MspI. J Lipid Res. 32:1991;1229-1233.
69. Ludwig E.H., McCarthy B.J. Haplotype analysis of human apolipoprotein B mutation associated with familial defective apolipoprotein B100. Am J Hum Genet. 47:1990;712-720.
70. Law A., Powell L.M., Brunt H., et al. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet. 1:1986;1301-1303.
71. Tybjærg-Hansen A., Steffensen R., Meinertz H., Schnohr P., Nordestgaard B.G. Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. N Engl J Med. 338:1998;1577-1584.